Internal Medicine Alert – August 15, 2014
August 15, 2014
View Issues
-
Risk of Developing Atrial Fibrillation with Use of Bisphosphonates
The risk of developing atrial fibrillation is increased by the use of oral or intravenous bisphosphonates, but the risk is relatively greater when the drug is given intravenously. -
Gloves Are Not Perfect
After caring for patients with Clostridium difficile infection, nearly 25% of health care workers were found to have hand contamination with C. difficile spores. -
Frailty: An Important Determinant of Outcome in Critical Illness
In this prospective study of older ICU patients (mean age, 67 years), frailty as assessed by a simple scale was present in one-third and was strongly associated with increased risk of adverse events, morbidity, and mortality. -
Tavaborole Topical Solution, 5% (Kerydin¢â)
The first oxaborole antifungal has been approved for the treatment of fungal toenail infection. Tavaborole is a topical solution that is applied daily to the infected nail. It is marketed by Anacor Pharmaceuticals as Kerydin¢â -
Clinical Briefs
-
Is This a Normal ECG?
The ECG in the Figure was obtained from a patient with atypical chest pain. Is this a normal ECG? If not, why not?